Congenital Hearing Loss

sickle cell blood cells :: Article Creator Philadelphia Health Providers And Patients Seek A New Treatment Roadmap For Sickle Cell Disease After Drug Recall From Philly and the Pa. Suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! About two weeks ago, Ediomi Utuk-Lowery got an unexpected email. It was about a medication called voxelotor, which she has been taking to help manage her sickle cell disease, an inherited blood disorder. "I read the email, I was like, wait a minute, this can't be real," Utuk-Lowery said. "So I Googled it, and then I saw the articles, and I'm just like, no, this cannot be happening." The email explained that Pfizer, which manufactured and sold voxelotor under the brand name Oxbryta, voluntarily pulled the medication from shelves over the company's safety concerns in ongoing clinical trials outside the United States. WHYY thanks our

williams syndrome heart :: Article Creator From A Hurting Heart: On The Execution Of Marcellus Williams Marcellus Williams. There's no other way to write this outside of the extensive curse words I want to use: What, the actual, hell? How on earth does the United States have such a deeply flawed system of injustice that the state of Missouri executed a man that both the defense and prosecution believed was innocent? My heart is heavy. How about you? The state of Missouri executed Marcellus Williams on Tuesday, September 24. He was convicted of a murder committed in 1998. It was apparently a burglary gone wrong that resulted in the killing of former newspaper reporter Lisha Gayle. Williams was sentenced to death. There is significant evidence that Williams was wrongly convicted. The original prosecutor, Wesley Bell, sought to block the execution out of concerns about the trial. Bell had concern about two of the primary trial witnesses as

having an extra x chromosome :: Article Creator Exploring Autoimmune Prevalence And X Chromosome Inactivation In Systemic Lupus Erythematosus Autoimmune diseases, including systemic lupus erythematosus (SLE), are more common in women than men, and scientists are still trying to figure out why. One reason may be related to the number of X chromosomes a person has. Typically, females have two X chromosomes (XX), and males have one X and one Y (XY). However, some males have an additional X chromosome (XXY), and some females have an extra X too (XXX). The additional X chromosome in females might play a role in the predisposition to autoimmune diseases like Sjogren's syndrome and lupus. A recent study examines how inactivation of the X chromosome might be connected to SLE.  In the study, researchers examined blood samples from 181 people with SLE to determine which X chromosome was inactivated. Normally, one X chromosome is inactive in every cell, bu

cftr gene cystic fibrosis :: Article Creator What Is Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)? The cystic fibrosis transmembrane conductance regulator (CFTR) is a complex protein that helps maintain fluid balance in several organs. Mutations in the CFTR protein can lead to symptoms of cystic fibrosis (CF). The CFTR is a type of complex protein molecule. Proteins are molecules made up of amino acids. Each cell in the body contains proteins. Proteins play several important roles. They help build and repair body cells, control many bodily functions, and help transport nutrients around the body. The CFTR protein helps balance water and salt in many of the organs. CF is a genetic condition in which mucus builds up in the lungs and digestive system. People with CF have changes to their CFTR protein that affect how it works. This can affect the body in several ways. The CFTR protein functions as